The Campbell’s Company (CPB) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
13 Jan, 2026Opening remarks and agenda
The meeting was convened by the Chair, with introductions of executive leadership and director nominees, and confirmation of a quorum for business proceedings.
The agenda included four management proposals and one shareholder proposal, with voting procedures and Q&A sessions outlined.
Rules of conduct and access to prior meeting minutes were provided to shareholders.
Shareholder proposals
A shareholder proposal called for a diversity audit, citing concerns over management diversity and the financial materiality of the issue.
The Board opposed the proposal, stating existing diversity initiatives and reporting were sufficient and the audit would not add value.
Overview of voting outcomes
All 12 director nominees were elected for one-year terms.
Ratification of the independent auditor, approval of executive compensation, and a corporate name change were all approved.
The shareholder proposal for a diversity audit was not approved.
Latest events from The Campbell’s Company
- Net sales and earnings fell, prompting lower guidance and accelerated cost-saving actions.CPB
Q2 202611 Mar 2026 - Snacking and premium brands drive growth, with margin expansion and meals recovery underway.CPB
4th Annual Evercore ISI Consumer and Retail Conference3 Feb 2026 - Q3 net sales up 6% and adjusted EPS up 10%, led by Sovos Brands and margin gains.CPB
Q3 202431 Jan 2026 - Q4 adjusted EPS up 26% with Sovos integration; FY25 targets 9–11% sales growth.CPB
Q4 202423 Jan 2026 - Targets 2–3% sales and 7–9% EPS growth by 2027, led by brand focus, innovation, and supply chain excellence.CPB
Investor Day 202421 Jan 2026 - Net sales up 10% to $2.8B, adjusted EPS down 2%, dividend raised, CEO transition announced.CPB
Q1 202512 Jan 2026 - Flat organic growth expected in 2026, with snacks stabilizing and brand investment prioritized.CPB
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025 - Sales and earnings declined, but cost savings and new partnerships support guidance.CPB
Q1 202611 Dec 2025 - Net sales rose 9% on acquisitions, but organic sales and margins declined amid cost pressures.CPB
Q2 20258 Dec 2025